Article
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer.
BMC cancer - 25 Feb 2021
Araujo Luiz Henrique, Souza Bianca Mendes, Leite Laura Rabelo, Parma Sabrina A F, Lopes Natália P, Malta Frederico S V, Freire Maíra C M
Abstract excerpt
BACKGROUND: KRAS is the most frequently mutated oncogene in cancer, however efforts to develop targeted therapies have been largely unsuccessful. Recently, two small-molecule inhibitors, AMG 510 and MRTX849, have shown promising activity in KRAS G12C-mutant solid tumors. The current study aims to assess the molecular profile of KRAS G12C in colorectal (CRC) and non-small-cell lung cancer (NSCLC) tested in a...
Topics
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Female
- GTP Phosphohydrolases
- Humans
- Lung Neoplasms
- Male
- Membrane Proteins
